FiercePharma  3 hrs ago  Comment 
Glaxo, say hello to another Advair rival in Germany and Sweden. Monday, Indian generics maker Cipla rolled out its copy of GSK's respiratory behemoth in the two European countries, and the company's CEO says more are on the way.  8 hrs ago  Comment 
STOCKHOLM (dpa-AFX) - Sweden's current account surplus decreased in the second quarter largely due to a fall in visible trade surplus, a report from Statistics Sweden showed Tuesday. The current account surplus decreased to SEK 48.7 billion...
The Hindu Business Line  8 hrs ago  Comment 
The stock of drug major Cipla touched a new high of ₹575 on Tuesday, an 8 per cent gain over its previous closing price. This followed the long-awaited approval for its combination inhal...
The Economic Times  Sep 2  Comment 
The launch paves way for a re-rating of the stock as the drugmaker could look at other key markets like UK, France and Spain next, say analysts.
Reuters  Sep 1  Comment 
Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product.  Sep 1  Comment 
STOCKHOLM (dpa-AFX) - Sweden's manufacturing activity grew at a slower rate in August, a report from Swedbank showed Monday. The manufacturing purchasing managers' index, or PMI, fell to 51 in August from 55.1 in July. This was driven...
Automotive World  Aug 29  Comment 
The District court of Vänersborg, Sweden, today August 29 approved the application for reorganization from National Electric Vehicle Sweden AB. The District court has appointed Mr. Lars Eric Gustafsson, Attorney at Hamilton law firm in Stockholm,...
Wall Street Journal  Aug 29  Comment 
Bombardier's CSeries jetliner has suffered another setback as Sweden's Braathens Aviation said it will step back from its role as the plane's first operator and may seek other changes to delivery plans.


Companies in the Investing in Sweden Industry (476)

  • Company icon
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki